Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The RANK/RANKL/osteoprotegerin system in rheumatoid arthritis: new insights from animal models.

× No keyword cloud information.

13 in total

1. The impact of serial radon and hyperthermia exposure in a therapeutic adit on pivotal cytokines of bone metabolism in rheumatoid arthritis and osteoarthritis.

Authors: Uwe Lange; Gabriel Dischereit; Ingo Tarner; Klaus Frommer; Elena Neumann; Ulf Müller-Ladner; Bernhard Kürten
Journal: Clin Rheumatol Date: 2016-04-06 Impact factor: 2.980

2. Denosumab in postmenopausal osteoporosis: what the clinician needs to know.

Authors: E Michael Lewiecki
Journal: Ther Adv Musculoskelet Dis Date: 2009-02 Impact factor: 5.346

3. [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?].

Authors: E Neumann
Journal: Z Rheumatol Date: 2006-09 Impact factor: 1.372

Review 4. [Inflammation and bone metabolism].

Authors: E Neumann; U Müller-Ladner; K W Frommer
Journal: Z Rheumatol Date: 2014-05 Impact factor: 1.372

5. Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes.

Authors: Y Li; D Li; Y Li; S Wu; S Jiang; T Lin; L Xia; H Shen; J Lu
Journal: Osteoporos Int Date: 2015-11-16 Impact factor: 4.507

6. Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE(2), and MMP-13 expression.

Authors: Zhi-feng Wei; Xiao-lan Jiao; Ting Wang; Qian Lu; Yu-feng Xia; Zheng-tao Wang; Qing-long Guo; Gui-xin Chou; Yue Dai
Journal: Acta Pharmacol Sin Date: 2013-02-11 Impact factor: 6.150

Review 7. Integrins and their ligands in rheumatoid arthritis.

Authors: Torsten Lowin; Rainer H Straub
Journal: Arthritis Res Ther Date: 2011-10-28 Impact factor: 5.156

8. Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis.

Authors: Isidoro González-Álvaro; Ana M Ortiz; José María Alvaro-Gracia; Santos Castañeda; Belen Díaz-Sánchez; Inmaculada Carvajal; J Alberto García-Vadillo; Alicia Humbría; J Pedro López-Bote; Esther Patiño; Eva G Tomero; Esther F Vicente; Pedro Sabando; Rosario García-Vicuña
Journal: PLoS One Date: 2011-12-29 Impact factor: 3.240

9. Denosumab: an investigational drug for the management of postmenopausal osteoporosis.

Authors: E Michael Lewiecki
Journal: Biologics Date: 2008-12

10. Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis.

Authors: Jeong Yeon Kim; Eun Young Lee; Eun Bong Lee; Yun Jong Lee; Hyun Jung Yoo; Jiyong Choi; Yeong Wook Song
Journal: Arthritis Res Ther Date: 2012-08-17 Impact factor: 5.156